Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company engaged in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company focuses on addressing chronic pain and exploring the potential of cannabis-based medicines for other conditions, including autism.
- Chronic pain treatment
- Cannabis-based medicines
- Cannabinoid drug development
Locations
Competitors
Oxford Cannabinoid Technologies is a biotech company established in 2017, focused on developing non-addictive pain medications derived from cannabinoids.
Canna Capital is an investment company focused on identifying and pursuing opportunities in the medical cannabis sector.
Derby Pharma International Limited is dedicated to supporting health through innovative drug development and testing.
Company Details
Celadon Pharmaceuticals is operated by Celadon Pharmaceuticals Limited and is a Active company incorporated on 31 August 2018 with the registered office located in London, Greater London. Celadon Pharmaceuticals Limited was registered 7 years ago.
Status
Active
Size
Small
Directors
11
Age
7 years old
Employees
27
Turnover
£75K
Total Assets
£9.22M
Cash in Bank
£1.26M
Total Liabilities
-£6.06M